Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 6:9:869.
doi: 10.3389/fonc.2019.00869. eCollection 2019.

Exosomes in Cancer Radioresistance

Affiliations
Review

Exosomes in Cancer Radioresistance

Jie Ni et al. Front Oncol. .

Abstract

Radiation is a mainstay of cancer therapy. Radioresistance is a significant challenge in the treatment of locally advanced, recurrent and metastatic cancers. The mechanisms of radioresistance are complicated and still not completely understood. Exosomes are 40-150 nm vesicles released by cancer cells that contain pathogenic components, such as proteins, mRNAs, DNA fragments, non-coding RNAs, and lipids. Exosomes play a critical role in cancer progression, including cell-cell communication, tumor-stromal interactions, activation of signaling pathways, and immunomodulation. Emerging data indicate that radiation-derived exosomes increase tumor burden, decrease survival, cause radiation-induced bystander effects and promote radioresistance. In addition, radiation can change the contents of exosomes, which allows exosomes to be used as a prognostic and predictive biomarker to monitor radiation response. Therefore, understanding the roles and mechanisms of exosomes in radiation response may shed light on how exosomes play a role in radioresistance and open a new way in radiotherapy and translational medicine. In this review, we discuss recent advances in radiation-induced exosome changes in components, focus on the roles of exosome in radiation-induced bystander effect in cancer and emphasize the importance of exosomes in cancer progression and radioresistance for developing novel therapy.

Keywords: bystander; cancer; exosomes; radioresistance; radiotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The bystander effect of exosomes in cancer radiotherapy. The mechanistic diagram displaying the effect of radiation-induced exosomal proteins and microRNAs in mediating cellular and molecular changes in RIBE. Created with BioRender.
Figure 2
Figure 2
Putative mechanisms of IR-induced exosomes in promoting cancer radioresistance. AHIF, a natural antisense transcript; circRNA, circular RNA; IR, irradiation; lncRNA, long non-coding RNA; miRNA, microRNA; mRNA, messenger RNA. Created with BioRender.

References

    1. Barton MB, Jacob S, Shafiq J, Wong K, Thompson SR, Hanna TP, et al. . Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol. (2014) 112:140–4. 10.1016/j.radonc.2014.03.024 - DOI - PubMed
    1. Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, et al. . Expanding global access to radiotherapy. Lancet Oncol. (2015) 16:1153–86. 10.1016/S1470-2045(15)00222-3 - DOI - PubMed
    1. Yaromina A, Krause M, Baumann M. Individualization of cancer treatment from radiotherapy perspective. Mol Oncol. (2012) 6:211–21. 10.1016/j.molonc.2012.01.007 - DOI - PMC - PubMed
    1. Ni J, Bucci J, Chang L, Malouf D, Graham P, Li Y. Targeting MicroRNAs in prostate cancer radiotherapy. Theranostics. (2017) 7:3243–59. 10.7150/thno.19934 - DOI - PMC - PubMed
    1. Rycaj K, Tang DG. Cancer stem cells and radioresistance. Int J Radiat Biol. (2014) 90:615–21. 10.3109/09553002.2014.892227 - DOI - PMC - PubMed

LinkOut - more resources